Related Experiment Video
Updated: Jan 3, 2026
10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
3.1K
New insights into human beta cell biology using human pluripotent stem cells
Nur Shabrina Amirruddin1, Blaise Su Jun Low1, Kok Onn Lee2
1Stem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), A*STAR, Proteos, Singapore, 138673, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.
Seminars in Cell & Developmental Biology
|November 24, 2019
Summary
Human pluripotent stem cells (hPSCs) are differentiated into pancreatic beta-like cells for diabetes research and therapy. These cells offer a valuable model for studying diabetes and screening new treatments.
Area of Science:
- Stem cell biology
- Endocrinology
- Diabetes research
Background:
- Pancreatic beta-cells regulate glucose homeostasis; their dysfunction causes diabetes.
- Human tissues for transplantation are scarce, limiting diabetes treatment options.
- Human pluripotent stem cells (hPSCs) can be differentiated into functional beta-like cells.
Purpose of the Study:
- To review the utility of hPSC-derived beta-like cells in modeling diabetes.
- To compare hPSC-derived beta-like cells with existing models (animal, ex vivo islets, cell lines).
- To discuss their application in therapeutic compound screening and understanding beta-cell biology.
Main Methods:
- Review of current literature on hPSC differentiation into beta-like cells.
- Comparative analysis of hPSC-derived models against established diabetes models.
- Evaluation of hPSC-derived cells for drug discovery and disease mechanism studies.
Main Results:
- hPSC-derived beta-like cells serve as a robust platform for modeling human beta-cell defects in diabetes.
- These cells provide a valuable alternative to scarce human islets and animal models.
- Applications include disease mechanism elucidation and high-throughput screening of therapeutic agents.
Conclusions:
- hPSC-derived beta-like cells represent a significant advancement in diabetes research and potential cell therapy.
- This human cell-based platform offers unique insights into beta-cell biology and diabetes pathogenesis.
- Further research will refine their use in regenerative medicine and personalized therapeutics.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
01:06Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
01:13Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K